momelotinib,Danazol
sierra oncology,lannett
['momelotinib']
momelotinib is the first and only jak1 and jak2 inhibitor that also decreases hepcidin thru acvr1 inhibition. this provides benefit for pts with myelofibrosis and anemia, which is an unmet need in mf treatment #ash22 
Heme/Onc Fellow @ClevelandClinic| Proud @PittTweet, @WakeForestMed and @OhioStateIMRes Alum| Opinions Are My Own| Most Tweets Will Involve Soccer